000			05240nam a22006015i 4500
999			_c9914 _d9914
001			9914
003			ES-VaUE
005			20210524142717.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			201123s2021 gw | o |||| 0|eng d
020			_a3030523993
024	7		_a10.1007/978-3-030-52399-2 _2doi
040			_bspa _dES-VaUE
050			_aR858 _b.B63 2021 EB
072		7	_aMBN _2bicssc
072		7	_aMED076000 _2bisacsh
072		7	_aMBN _2thema
082	0	4	_a613 _223
082	0	4	_a614.44 _223
245	1	0	_aPersonalised Health Care _bFostering Precision Medicine Advancements for Gaining Population Health Impact _cedited by Stefania Boccia, Róza Ádány, Paolo Villari, Martina C. Cornel, Corrado De Vito, Roberta Pastorino
250			_a1st ed. 2021
264		1	_aCham _bSpringer International Publishing _bImprint: Springer _c2021
300			_a1 online resource (XIX, 120 p. 15 illus., 13 illus. in color.)
336			_atext _btxt [ _2rdacontent]
337			_acomputer _bc [ _2rdamedia]
338			_aonline resource _bcr [ _2rdacarrier]
490	1		_aSpringerBriefs in Public Health _x2192-3698
505	0		_aIntroduction (Boccia) -- 1. Chapter 1: Identification of biomarkers for the prevention of chronic disease (Editors: Adany, Boccia) -- 2. Chapter 2: Evaluation of predictive genomic applications (Editor: Villari). -3. Chapter 3: Ethico-legal and policy issues surrounding personalised medicine (Editor: Sandor) -- olicy issue, with a focus on citizens and DTC) 3.4 Sandor (Legal issue) -- 4. Chapter 4: Roles and responsibilities of stakeholders in informing healthy individuals on their genome: a sociotechnical analysis (Editor: Cornel) -- 5. Chapter 5: Identification of organizational models for the provision of predictive genomic applications (Editor: De Vito)
520			_aPractitioners are increasingly adopting a personalised medicine approach to individually tailored patient care, especially disease diagnosis and treatment with the use of biomarkers. However, development and implementation of such approaches to chronic disease prevention need further investigation and concerted efforts for proper use in healthcare systems. This book provides high-quality, multidisciplinary knowledge from research in personalised medicine, specifically personalised prevention of chronic disease. It addresses different perspectives of prevention in the field, and is the outcome of a four-year work of the Personalized prevention of Chronic Disease (PRECeDI) Consortium, a multi-disciplinary and multi-professional team of experts. The Consortium jointly agreed to document and address the five aspects or domains of personalised medicine and prevention as individual chapters: • Identification of biomarkers for the prevention of chronic disease • Evaluation of predictive genomic applications • Ethico-legal and policy issues surrounding personalised medicine • Roles and responsibilities of stakeholders in informing healthy individuals on their genome: a sociotechnical analysis • Identification of organisational models for the provision of predictive genomic applications The book focuses on the Consortium's recommendations that are derived from each of these domains based on up-to-date evidence and research that the authors write, follow, and systematically organise and report. Personalisation of health care is, eventually, a driver of innovation in research and healthcare systems. With this SpringerBrief on Personalised Health Care: Fostering Precision Medicine Advancements for Gaining Population Health Impact, the Consortium provides further evidence of the clinical validity and utility of personalised medicine with special emphasis on the prevention of chronic diseases. The book is a useful resource for policy makers, industry and healthcare professionals, scientists, technology-sector professionals, investors, citizens, and private companies that need proper advice to realise the potential of personalised medicine
650		0	_aHealth promotion
650		0	_aHuman genetics
650		0	_aMedical policy
650		0	_aEthics
650		0	_aMedical laws and legislation
650		0	_aGenetics
650	1	4	_aHealth Promotion and Disease Prevention.
650	2	4	_aHuman Genetics.
650	2	4	_aHealth Policy.
650	2	4	_aEthics.
650	2	4	_aMedical Law.
650	2	4	_aGenetics and Genomics.
700	1		_aBoccia, Stefania., _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aÁdány, Róza., _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aVillari, Paolo., _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aCornel, Martina C., _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aDe Vito, Corrado., _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aPastorino, Roberta., _eeditor. _4edt. _4http://id.loc.gov/vocabulary/relators/edt
776			_z3-030-52398-5
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-52399-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942			_2lcc _cLE
998			_db